All amounts appropriated or made available under this Act are in addition to the amounts already appropriated for the relevant fiscal year.  

HHS AGENCIES RECEIVE ADDITIONAL FUNDING FOR CORONAVIRUS RESPONSE 

This Act includes appropriations for the Centers for Disease Control and Prevention (CDC), the National Institute of Allergy and Infectious Disease (NIAID) which is part of the National Institutes of Health (NIH), and the Office of the Secretary.  

In addition to these agencies, the Food and Drug Administration (FDA) will receive $61 million for salaries and expenses related to responding to coronavirus 

Centers for Disease Control 

The CDC will receive an additional $2.2 billion, to be available through September 2022, for coronavirus preparedness and response:  

• At least $950 million is for grants or agreements with states, localities, territories, tribes, tribal organizations, urban Indian health organizations, or health service providers to conduct surveillance, epidemiology, lab capacity, infection control, mitigation, communications, and other preparedness and response activities. $475 million of this money is to be allocated within 30 days of enactment of the Act, which means by April 5, 2021. 
• At least $300 million must be for global disease detection and emergency response 
• $300 million will be transferred to the Infectious Diseases Rapid Response Reserve Fund. CDC will have to report to Congress in relation to this.  

• Money under the allocation to the CDC may be used for grants for construction, alternation, or renovation of non-federally owned facilities to improve preparedness and response capabilities at local and State level.  

National Institute of Allergy and Infectious Diseases 

The National Institute of Allergy and Infectious Diseases (NIAID) receives an additional $836 million that will be available until September 2024 for response to coronavirus.  

• At least $10 million of this will be transferred to the National Institute of Environmental Health Sciences for worker training to prevent and reduce exposure of hospital employees, first responders, and other workers at risk of exposure.  

HHS Office of the Secretary 

The Office of the Secretary receives the following: 

• An additional amount of $3.1 billion for the Public Health and Social Services Emergency Fund will be available through September 2024 for coronavirus response. Examples listed in the law include developing countermeasures and vaccines and the purchase of medical supplies (including vaccines, diagnostics, and therapeutics). 

• $2 million will be for the Office of the Inspector General (OIG) for oversight activities.  
• $100 million of this appropriation is for the Health Resources and Services Administration- Primary Health Care for grants under the Health Centers Program for coronavirus response 
• The Secretary can purchase vaccines using these funds and may take measures authorized under current law to ensure that vaccines, therapeutics, and diagnostics developed with funds from this Act are affordable in the commercial market 

• Affordable is not defined. 

• Products purchased with these funds may be deposited in the Strategic National Stockpile. 
• Funds under this allocation may be used for construction, alteration, or renovation of non-federally owned facilities for producing vaccines, therapeutics, or diagnostics if the Secretary determines it is necessary to secure sufficient supply.  

• An additional $300 million for the Public Health and Social Services Emergency Fund available until September 2024 to purchase products, including vaccines, diagnostics, and therapeutics, developed using the above allocated $3.1 billion. However, these funds are only if the initial allocation is exhausted.  

General Provisions for Funds Appropriated to HHS 

• The funds appropriated in this bill can be used to restore amounts incurred by HHS agencies related to coronavirus response that were prior to the enactment date of the bill.  
• The funds appropriated in this bill may be used to reimburse for costs for coronavirus response related to grants or agreements with States, localities, and other entities incurred between January 20, 2020 and March 6, 2020.  
• Any funds transferred from an appropriation detailed by a prior HHS submission to Congress dated February 2020 
• The Secretary must report to Congress by (30 days after enactment) a detailed spending plan of anticipated uses of the appropriated funds. The plan must be updated and submitted to relevant Committees every 60 days until September 30, 2024.  

HHS SECRETARY GIVEN WAIVER AUTHORITY RELATED TO MEDICARE TELEHEALTH SERVICES 

• This act gives the Secretary of HHS to authority to temporarily waive or modify Medicare requirements related to telehealth services provided during the public health emergency. 
• The Centers for Medicare and Medicaid Services (CMS) has already released a waiver in response to this authority. 

APPROPRIATIONS FOR OTHER AGENCIES, INCLUDING STATE DEPARTMENT AND SMALL BUSINESS ADMINISTRATION INCLUDED IN ACT 

• The Small Business Administration (SBA) $20 million for administrative expenses for the Disaster Loans Program Account 

• Coronavirus is deemed a disaster under the Small Business Act 

• $264 million for the Department of State 
• For USAID, $1 million for the Office of Inspector General and $435 million administered by USAID for global health programs, of which at least $200 million will be transferred to the Emergency Reserve Fund. 
• $300 million for international disaster assistance 
• Congress has dictated reporting requirements for these appropriations as well.